Concepedia

Yijing Ren

YR

Statistics

Publications

1

Citations

18

H-Index

1

Active since

2024

Affiliations

Crown Bioscience (China)(Current)

Yijing Ren is an author at Crown Bioscience (China) specializing in cancer immunology, checkpoint inhibitor therapy, and checkpoint inhibitor antibodies.

ORCID

Publications per year

2024–2024

1

Publications

1

ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation

Hui Yuwen, Huajing Wang, Tengteng Li et al. · Cancer Research · 2024 · 18 citations · Full text

Life Sciences, Immunology, Oncology +17

1–1 of 1